https://www.investing.com/news/pro/glaukos-corporation-pt-raised-to-54-at-citi-432SI-2863376

Glaukos Corporation (NYSE:NYSE:GKOS) Q2 2022 Earnings Conference Call August 03, 2022 04:30 PM ET Company Participants Chris Lewis - VP, IR and Corporate Affairs Tom Burns - Chairman and…

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound ’s (NASDAQ: MDWD ) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns. MediWound shares traded in a range of $1.6 to $1.76 on a day volume of 283.18 thousand shares, closed regular trading session at $1.67. The company shares are currently trading at $1.77, up 5.99 percent in the after-hours trading session. Alnylam (NASDAQ: ALNY ) announced positive results from the APOLLO-B Phase 3 study of Patisiran for the treatment of transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy. Alnylam shares traded in a range of $198 to $220.92 on a day volume of 8.54 million shares, closed regular trading session at $212.01. The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Glaukos ’ (NYSE: GKOS ) iStent infinite Trabecular Micro-Bypass System indicated for use in a standalone procedure to reduce elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma uncontrolled by prior medical and surgical therapy.

Glaukos (NYSE: GKOS ) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here''s what investors need to know about the announcement. Earnings Glaukos missed estimated earnings by 88.64%, reporting an EPS of $-0.83 versus an … Full story available on Benzinga.com

Glaukos press release (GKOS): Q2 Non-GAAP EPS of -$0.83 misses by $0.39.Revenue of $72.69M (-6.9% Y/Y) beats by $4.7M.The company expects 2022 net sales to be in the range of…

Today I am discussing the six most aggressive growth stocks to buy in July. They reflect huge potential growth in their sales and/or their earnings. That means their valuations may be quite high, reflecting optimism about that growth. Aggressive growth stocks tend to get bid up due to the market’s enthusiasm over the company’s future prospects. Typically, this relates primarily to sales growth trajectories. As a result, many of these stocks have high price-to-sales multiples. Moreover, in many cases, the high-growth stock does not have positive earnings yet. Or it may have very low adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) figures. As a result, the price-to-adjusted EBITDA, or enterprise value (EV)-to-adjusted EBITDA multiples typically are high. EBITDA is sort of a “poor man’s earnings.” It cuts corners to try to show that the company has positive income. But that company’s actual net income, and even its cash flow, are often negative. For example, by cutting out the real cash costs of interest and taxes, which most companies have to pay, EBITDA shows profitability.

Upgrades For Herbalife Nutrition Ltd (NYSE: HLF ), Jefferies upgraded the previous rating of Hold to Buy. For the first quarter, Herbalife Nutrition had an EPS of $0.99, compared to year-ago quarter EPS of $1.42. The stock has a 52-week-high of $54.45 and a 52-week-low of $19.30. At the end of the last trading period, Herbalife Nutrition closed at $19.71. According to Susquehanna, the prior rating for Southwest Airlines Co (NYSE: LUV ) was changed from Neutral to Positive. For the first quarter, Southwest Airlines had an EPS of $0.32, compared to year-ago quarter EPS of $1.72. At the moment, the stock has a 52-week-high of $56.33 and a 52-week-low of $34.36. Southwest Airlines closed at $36.83 at the end of the last trading period. For Ryan Specialty Holdings Inc (NYSE: RYAN ), Goldman Sachs upgraded the previous rating of Neutral to Buy. The current stock performance of Ryan Specialty Holdings shows a 52-week-high of $42.43 and a 52-week-low of $25.57. Moreover, at the end of the last trading period, the closing price was at $39.70.

Glaukos Corporation (GKOS) a health equipment maker focused on eye diseases such as Glaucoma, is trading higher in the morning hours Tuesday after Stifel upgraded its shares to Buy…

US Solar announced the groundbreaking of USS Giveback, its first community solar gardens with Black Hills Energy in Pueblo, Colorado. The 2-MW and 500-kW community solar arrays will serve businesses, residents, municipalities and low- to moderate-income service organizations in the greater Colorado area. As part of its commitment to Black Hills Energy and the community,…